Introduction {#s1}
============

NusG/Spt5 proteins are the only transcription factors that coevolved with RNA polymerase (RNAP) since the last universal common ancestor ([@bib39]). These proteins have an N-terminal domain (NTD) of mixed α/β topology connected to at least one β-barrel C-terminal domain (CTD) bearing a KOW motif *via* a flexible linker. The NTD binds across the DNA-binding channel, bridging the RNAP pincers composed of the β\' clamp and β lobe domains and locking elongating RNAP in a pause-resistant state ([@bib51]), a mechanism likened to that of processivity clamps in DNA polymerases ([@bib26]). The CTDs modulate RNA synthesis by making contacts to nucleic acids or to proteins involved in diverse cellular processes; *Escherichia coli* NusG binds either to termination factor Rho to silence aberrant transcription ([@bib37]; [@bib44]) or to ribosomal protein S10 to promote antitermination ([@bib46]) and transcription-translation coupling ([@bib11]).

In addition to housekeeping NusG, diverse bacterial paralogs, typified by *E. coli* RfaH, activate long operons that encode antibiotics, capsules, toxins, and pili by inhibiting Rho-dependent termination, an activity inverse to that of NusG ([@bib39]). To prevent interference with NusG, action of its paralogs must be restricted to their specific targets. Targeted recruitment is commonly achieved through recognition of nucleic acid sequences, for example, by alternative σ factors during initiation. Indeed, all RfaH-controlled operons have 12-nt operon polarity suppressor (*ops*) signals in their leader regions. RfaH is recruited at *ops* sites in vitro and in vivo ([@bib3]; [@bib6]) through direct contacts with the non-template (NT) DNA strand in the transcription bubble ([@bib3]), a target shared with σ ([@bib52]). However, *E. coli* NusG is associated with RNAP transcribing most genes and lacks sequence specificity ([@bib36]) arguing against an alternative recognition sites model.

In a working model, off-target recruitment of RfaH is blocked by autoinhibition ([Figure 1](#fig1){ref-type="fig"}). RfaH-CTD, unlike the CTDs of all other known NusG/Spt5 proteins, which adopt a β-barrel structure, folds as an α-helical hairpin that masks the RNAP-binding site on the NTD ([@bib8]). Contacts with the *ops* element in the NT DNA are thought to trigger domain dissociation, transforming RfaH into an open, active state in which the NTD can bind to RNAP ([@bib8]); consistently, destabilization of the domain interface enables sequence-independent recruitment ([@bib8]; [@bib53]). On release, the α-helical CTD spontaneously refolds into a NusG-like β-barrel ([@bib10]), classifying RfaH as a transformer protein ([@bib27]). Activated RfaH remains bound to the transcription elongation complex (TEC) until termination ([@bib6]), excluding NusG present in 100-fold excess ([@bib49]). The β-barrel CTD recruits the 30S subunit of the ribosome to leader sequences that lack Shine-Dalgarno elements *via* interactions with S10 ([@bib10]). These interactions could be either maintained throughout translation elongation or broken upon the 70S formation; evidence exists in support of either scenario ([@bib28]; [@bib48]). Following TEC dissociation, RfaH has been proposed to regain the autoinhibited state ([@bib57]), thus completing the cycle.

![Life cycle of RfaH.\
Available experimental data demonstrate RfaH recruitment to the *ops*-paused RNAP in vitro ([@bib3]) and in vivo ([@bib6]) *via* a hairpin in the NT DNA (this work). [@bib8] showed that destabilization of the interdomain interface was required for RfaH switch from the autoinhibited into the active state, and proposed that the RfaH-CTD refolds into a β-barrel upon release. The RfaH-CTD refolding and interactions with S10 were demonstrated by NMR spectroscopy, and functional evidence in support of their role in ribosome recruitment in vivo was reported ([@bib10]). A hypothesis that the autoinhibited state is regained after RfaH is released from TEC at a terminator has been proposed ([@bib57]) and awaits testing. The details of RfaH:RNAP contacts that mediate initial recruitment at *ops,* the molecular mechanism of ribosome recruitment, and hypothetical coupling of transcription and translation by RfaH ([@bib10]) remain to be investigated.β\'CH, β\' clamp helices; βGL, β gate loop.](elife-36349-fig1){#fig1}

A model of *E. coli* RfaH bound to *Thermus thermophilus* TEC was constructed by arbitrarily threading the NT DNA (absent in the X-ray structure) through the TEC ([@bib8]). While subsequent functional analysis of RfaH supports this model ([@bib7]), the path of the NT DNA and the details of *ops*:RfaH interactions remain unclear. The NT DNA is flexible in the TEC ([@bib25]) and could be trapped in a state incompatible with productive elongation; RfaH/NusG and yeast Spt5 have been proposed to constrain the NT strand to increase processivity ([@bib13]; [@bib40]). Direct contacts to the NT DNA have been demonstrated recently for *Bacillus subtilis* NusG ([@bib63]) and *Saccharomyces cerevisiae* Spt5 ([@bib13]).

Here we combined structural and functional analyses to dissect RfaH:*ops* interactions. Our data argue that *ops* plays two roles in RfaH recruitment: it halts RNAP to aid loading of RfaH and makes specific contacts with RfaH-NTD. Strikingly, we found that a small hairpin extruded from the NT DNA is required for RfaH recruitment, demonstrating how NT DNA flexibility could be harnessed for transcriptional regulation in this and potentially many other systems.

Results {#s2}
=======

Functional dissection of RfaH:*ops* interactions {#s2-1}
------------------------------------------------

Ubiquity of the *ops* sequence in RfaH targets implies a key role in RfaH function. First, *ops* is a representative of class II signals that stabilize RNAP pausing through backtracking, a finding that predates demonstration of direct *ops*:RfaH interactions ([@bib2]). Native-elongation-transcript sequencing analysis revealed that *ops* matches the consensus pause signal ([Figure 2A](#fig2){ref-type="fig"}) and is one of the strongest pauses in *E. coli* ([@bib30]; [@bib60]). The observation that all experimentally validated *E. coli* RfaH targets ([@bib6]) share a pause-inducing TG dinucleotide ([@bib12]; [@bib60]) at positions 11 and 12 ([Figure 2A](#fig2){ref-type="fig"}) suggests that delaying RNAP at the *ops* site may be necessary for loading of RfaH. Second, *ops* bases are expected to make specific contacts to RfaH-NTD. However, potential interactions with RfaH are restricted to the central 5--6 nts of *ops* in the NT DNA strand, as these are expected to be exposed on the surface of the *ops*-paused RNAP ([@bib25]). Third, binding to *ops* could induce conformational changes in RfaH-NTD that destabilize the interdomain interface to trigger RfaH activation. Finally, pausing at *ops* could be required for ribosome recruitment, a key step in RfaH mechanism ([Figure 1](#fig1){ref-type="fig"}). In the case of RfaH, pausing could favor 30S loading at sites lacking canonical ribosome binding sites either kinetically or by remodeling the nascent RNA.

![Contribution of individual *ops* bases to RNAP pausing and RfaH recruitment.\
(**A**) Consensus pause and *E. coli ops* sequences. (**B**) Expression of *luxCDABE* reporter fused to *ops* mutants in the absence and presence of RfaH determined in three independent experiments, each with three biological replicates (see source file), is presented as average ± standard deviation. Only the data obtained in the presence of RfaH are plotted; the levels of expression in the absence of RfaH are very low. RfaH effect, the ratio of *lux* activities observed with and without RfaH, is shown below each mutant. (**C**) In vitro analysis of *ops* mutants. Transcript generated from the T7A1 promoter on a linear DNA template is shown on top; the transcription start site (bent arrow), *ops* element (green box), and transcript end are indicated. Halted A24 TECs were formed as described in Materials and Methods on templates with single substitutions in the *ops* element. Elongation was restarted upon addition of NTPs and rifapentin in the absence or presence of 50 nM RfaH. Aliquots were withdrawn at 10, 20, 40, 80, 160, 320, 640, and 1280 s and analyzed on 8% denaturing gels. Positions of the paused and run-off transcripts are indicated with arrows. Pause sites within the *ops* region are numbered relative to the *ops* consensus sequence and color-coded. Results with WT, C3G, G5A, and G12C *ops* variants are shown, for all other variants see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. (**D**) Analysis of RfaH effects in vitro (from (**C**)). The assays were performed in triplicates. RfaH effects at U11 reflect the antipausing modification of RNAP by RfaH. RfaH effects at G12/C13 reflect RfaH binding to the NT DNA strand, which hinders RNAP escape from *ops*. Fractions of U11 RNA (left) and G12 +C13 RNAs (right) at 20 s in the absence or the presence of RfaH, presented as average ± standard deviation from three independent experiments. RfaH effects (determined as a ratio of RNA fractions with *vs*. without RfaH) are shown below the variant. The core *ops* region is indicated by a black box.\
10.7554/eLife.36349.005Figure 2---source data 1.In vivo analysis of *ops* mutants by a *lux* reporter assay.\
10.7554/eLife.36349.006Figure 2---source data 2.In vitro analysis of the effect of *ops* mutants on RNAP pausing and RfaH recruitment.](elife-36349-fig2){#fig2}

To evaluate the roles of individual *ops* bases in vivo we used a luciferase (*lux*) reporter system ([@bib10]) in which RfaH increases expression \~40 fold with the wild-type (WT) *ops* ([Figure 2B](#fig2){ref-type="fig"}). We constructed reporters with single-base substitutions of all *ops* positions and measured the *lux* activity of the mutant reporters in the presence and absence of ectopically-expressed RfaH. The stimulating effect of RfaH was reduced by every *ops* substitution except for G2C ([Figure 2B](#fig2){ref-type="fig"}), with the strongest defects observed for substitutions G5A, T6A, G8C, and T11G. Since T11 is buried in the RNAP active site ([@bib25]), the strong effect of the T11G substitution is consistent with the essential role of pausing in RfaH activity.

To distinguish between the effects of the *ops* substitutions on RNAP pausing and RfaH binding, we used a defined in vitro system in which RNA chain extension is slowed by limiting NTPs. [Figure 2C](#fig2){ref-type="fig"} shows assays on the WT, C3G, G5A, and G12C templates, while representative results with all other variants are presented in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. The effect of RfaH was determined as ratio of RNA fractions in the presence *vs.* in the absence of RfaH ([Figure 2D](#fig2){ref-type="fig"}). On the WT *ops* template, RNAP paused at C9 and U11. In the presence of RfaH, pausing at U11 was significantly reduced, but strongly enhanced at G12, a well-documented consequence of RfaH recruitment attributed to persistent RfaH-NTD:DNA contacts ([@bib8]) and akin to σ-induced delay of RNAP escape from promoters and promoter-like sequences during elongation ([@bib43]). While C3G and T6A substitutions reduced RfaH recruitment and antipausing activity \~3 fold, G4C, G5A, A7T, and G8C abolished both effects completely ([Figure 2D](#fig2){ref-type="fig"}). Neither of these central bases was required for RNAP pausing ([Figure 2D](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), consistent with their variability in the consensus pause sequence ([Figure 2A](#fig2){ref-type="fig"}). Conversely, the G12C substitution eliminated the pause at U11, making measurements of RfaH antipausing activity unreliable, but did not abrogate RfaH recruitment ([Figure 2C,D](#fig2){ref-type="fig"}), suggesting that pausing at U11 is dispensable for RfaH binding when RNAP is transcribing slowly.

Observations that RfaH is recruited to RNAP transcribing the G12C template raised a possibility that recruitment may not be restricted to the U11 position; for example, on this template, RNAP also pauses at the C9 position. To determine whether the entire *ops* element has to be transcribed to recruit RfaH, we assembled TECs on a scaffold in which RNAP is halted three nucleotides upstream from the *ops* site and walked them in one-nt steps to the *ops* pause at U11 ([Figure 3](#fig3){ref-type="fig"}). To probe RfaH recruitment, we used footprinting with Exo III. In a post-translocated TEC, RNAP protects 14 bp upstream from the RNAP active site (inferred from the position of the RNA 3' end) from Exo III, in a pre-translocated TEC -- 15 bp ([@bib41]). When bound, RfaH alters the trajectory of the upstream DNA duplex to protect additional 6--7 bp of DNA from Exo III ([@bib42]). We observed that RfaH induces a strong block to Exo III at U11 ([Figure 3](#fig3){ref-type="fig"}), as expected based on previous studies ([@bib3]). RfaH was also recruited to TECs halted at C9 and G10, but not to G8 TEC in which Exo III was able to digest up to 14 bp of the upstream DNA ([Figure 3](#fig3){ref-type="fig"}). We conclude that RfaH can bind to TECs halted two nucleotides ahead of the *ops* site. This 'out-of-register' recruitment may be explained by lateral movements of RNAP, which effectively shift the *ops* position ([Figure 3](#fig3){ref-type="fig"}). In the absence of RfaH, RNAP halted at U11 can backtrack by 2--3 nt and by one nt at G10, whereas C9 TECs are resistant to backtracking ([@bib42]); in all three TECs, the same region of the NT DNA will be accessible to RfaH, at least in a fraction of complexes; see Discussion.

![RfaH recruitment to RNAP transcribing through the *ops* element.\
(**A**) Schematic of Exo III footprinting of free and RfaH-bound TECs. Numbers indicate the upstream footprint boundaries relative to the RNA 3' end. (**B**) The G8 TEC was assembled on the scaffold, with RNA and template (T) DNA strands labeled with \[γ^32^P\]-ATP and T4 polynucleotide kinase (PNK), and walked in one-nucleotide steps to C9, G10, and U11 positions in the presence of the matching NTP substrates. (**C**) RfaH was added to 50 nM, where indicated. Following the addition of Exo III, the reactions were quenched at indicated times (0 represents an untreated DNA control) and analyzed on a 12% urea-acrylamide (19:1) gel in 0.5X TBE. Numbers indicate the distance from the RNA 3' end. Hypothetical TEC structures are shown below. G8 and C9 complexes are predominantly post-translocated, as indicated by 14 bp protection of the upstream DNA. In G10 TEC, the pre-translocated state (15 bp protection) is observed, and in U11 an additional backtracked state (16 bp protection). Exo III may counteract backtracking; the sensitivity of the nascent RNA in G10 and U11 TECs to GreB-assisted cleavage ([@bib42]) was used to infer the translocation states shown in the schematics.](elife-36349-fig3){#fig3}

Structural analysis of RfaH:*ops* contacts {#s2-2}
------------------------------------------

Strong effects of substitutions of *ops* bases 3 through 8 on RfaH recruitment but not on RNAP pausing ([Figure 2D](#fig2){ref-type="fig"}) support a model in which these nucleotides make direct contacts with RfaH. To visualize the molecular details of RfaH:DNA interactions, we determined a crystal structure of RfaH bound to a 9-nt *ops* DNA encompassing bases G2 -- G10 (*ops*9) at a resolution of 2.1 Å ([Figure 4A](#fig4){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). The asymmetric unit contains two molecules of the complex, in which RfaH maintains the closed, autoinhibited state typical for free RfaH ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}, ([@bib8]). The DNA binds to a basic patch on RfaH-NTD opposite the RNAP/RfaH-CTD binding site and forms a hairpin structure ([Figure 4B](#fig4){ref-type="fig"}).

![Specific recognition of *ops* by RfaH.\
(**A**) Crystal structure of the RfaH:*ops*9 complex with the 2F~o~ -- F~c~ electron density map contoured at 1 σ. (**B**) Structure of RfaH:*ops*9 complex with RfaH shown in surface representation, colored according to its electrostatic potential and *ops*9 as sticks. (**C**) Details of RfaH:*ops9* interactions. Hydrogen bonds are shown as black dashed lines. RfaH residues that interact with *ops* are labeled in green. Alanine substitutions of RfaH residues that make base-specific contacts to G5 and T6 *via* their side chains and that compromise RfaH recruitment ([@bib7]) are highlighted in red (strongly defective) and orange (moderately defective). (**D**) RfaH:*ops* interactions in solution. \[^1^H, ^15^N\]-HSQC spectra of 110 μM \[^13^C, ^15^N\]-RfaH titrated with 803 μM *ops*12 DNA. Arrows indicate changes of chemical shifts. Selected signals are labeled. (**E**) Mapping of normalized chemical shift perturbations observed in (**D**) on the RfaH:*ops9* structure.\
10.7554/eLife.36349.011Figure 4---source data 1.Analysis of the chemical shift perturbations during the HSQC-titration of ^15^N-RfaH with *ops*12.](elife-36349-fig4){#fig4}
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###### Data collection and refinement statistics

  Data collection                    
  ---------------------------------- -------------------------------
  Wavelength (Å)                     0.9184
  Space group                        *P*1
  Unit cell parameters               
  *a*, *b*, *c* (Å)                  36.309/43.187/61.859
  α, β, γ (°)                        80.449/75.485/75.392
  Resolution (Å)^a^                  41.55--2.1 (2.2--2.1)
  Unique/observed reflections^a,b^   19,931/107,345 (2,633/14,210)
  *R*~sym~ (%) ^a,c^                 6.3 (42.9)
  *I*/σ*I*^a^                        13.96 (3.47)
  Completeness (%)^a^                97.3 (97.9)
  Molecules per asymmetric unit      2
  Refinement statistics              
  *R*~work~ (%)^d^                   18.62
  *R*~free~ (%)^e^                   23.34
  Number of atoms                    
  Protein                            4283
  Nucleic acid                       574
  Water                              116
  B-factors                          
  Protein                            56.062
  Nucleic acid                       87.427
  water                              48.058
  r.m.s. deviations                  
  Bond lengths (Å)                   0.013
  Bond angles (°)                    1.149

^a^Highest-Resolution shell values are given in parentheses.

^b^Friedel mates were not treated as independent reflections.

^c^*R*~sym~ = Σ~h~ Σ~I~ \| *I*~i~(*h*) - \<*I*(*h*)\> \| / Σ~h~Σ~i~*I*(*h*); where *I* are the independent observations of reflection *h*.

^d^*R*~work~ = Σ~h~ \|\|*F*~obs~\| - \|*F*~calc~\|\| / Σ~h~ \|*F*~obs~\|.

^e^The free *R*-factor was calculated from 5 % of the data, which were removed at random before the structure was refined.

The DNA:protein interface encompasses 420 Å^2^. The hairpin loop comprises G4-A7, with T6 flipped out so that its nucleobase is completely exposed. The other nucleobases of the loop make stacking interactions. Flipped T6 inserts into a deep, narrow, positively charged pocket on RfaH-NTD, which is mainly formed by H20, R23, Q24, and R73 located in helices α1 and α2. G5 packs against the positive surface next to this cavity ([Figure 4B](#fig4){ref-type="fig"}). RfaH-NTD exclusively contacts nucleotides in the loop region, involving K10, H20, R23, Q24, T68, N70, A71, T72, R73, G74, and V75 ([Figure 4C](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Some well-ordered water molecules are located in the *ops*-binding region, but only one participates in the recognition of a base (G4). Base-specific interactions with RfaH-NTD are made by G4, G5, and T6 ([Figure 4C](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}); however, only G5 and T6 form a hydrogen-bond network with RfaH-NTD that may underlie sequence-specific recognition. The side chains of K10, H20, R23, and R73 directly interact with the *ops* DNA ([Figure 4C](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}) and no aromatic residues for stacking interactions are located near T6 or G5. Thus, contacts between only two nucleobases and four amino acids mediate specific recognition of *ops* by RfaH. Observations that single Ala substitutions of each RfaH side chain that makes base-specific contacts to G5 and T6 ([Figure 4C](#fig4){ref-type="fig"}) compromise RfaH recruitment to the *ops*-pausedTEC ([@bib7]) argue that the RfaH:DNA contacts observed in the binary *ops*9:RfaH complex are functionally important.

The stem of the DNA hairpin is formed by base pairs C3:G8 and G2:C10, with T9 being flipped out. The G2:C10 base pair is likely an artifact of crystal packing as the stems of neighboring DNA molecules stack on each other ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}) and could not form in a TEC that contains a 10--11 nt bubble. In contrast, the C3:G8 base pair is compatible with the TEC structure and may be physiologically relevant. C3G and G8C substitutions reduce and abolish RfaH recruitment ([Figure 2C,D](#fig2){ref-type="fig"}), yet these bases lack specific contacts with RfaH ([Figure 4C](#fig4){ref-type="fig"}), suggesting that a hairpin structure may be necessary.

The NT DNA hairpin is required for RfaH recruitment {#s2-3}
---------------------------------------------------

To corroborate the crystallographic data, we carried out solution-state NMR analyses. In the \[^1^H\]-NMR spectrum of *ops*9 the single peak at \~13 ppm is characteristic of an imino proton signal of a G or T nucleobase in a DNA duplex, indicating the existence of a hairpin with a single base pair in solution ([Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}). Next, we titrated ^15^N-labeled RfaH with WT *ops* (*ops*12) and recorded \[^1^H,^15^N\]-HSQC spectra after each titration step ([Figure 4D](#fig4){ref-type="fig"}). Mapping of the normalized chemical shift perturbations ([Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}) on the structure of the RfaH:*ops*9 complex revealed a continuous interaction surface comprising mainly helices α1 and α2 that perfectly matched the DNA-binding site observed in the crystal structure ([Figure 4E](#fig4){ref-type="fig"}). The signals of ^15^N-RfaH-CTD were not affected during the titration, indicating that binding to the *ops* DNA is not sufficient to induce domain dissociation.

The above results demonstrate that base pair C3:G8 forms both in solution and in the crystal of the binary *ops*9:RfaH complex. To evaluate if this hairpin could form in the context of the TEC, we modeled RfaH-NTD bound to the *ops*-paused TEC ([Figure 5A](#fig5){ref-type="fig"}) based on a recent cryo-EM structure of the *E. coli* TEC ([@bib25]) using our *ops*9:RfaH structure. Since NusG and its homologs share the RNAP-binding mode ([@bib7]; [@bib9]; [@bib16]; [@bib46]), the crystal structure of *Pyrococcus furiosus* Spt5 bound to the RNAP clamp domain ([@bib26]; [@bib33]) served as a template for modeling. The NT DNA hairpin observed in the *ops*9:RfaH structure could be readily modeled into the TEC. In the modeled complex, RfaH-NTD binds to the β' clamp helices (β'CH) so that the β-hairpin of RfaH, consisting of β-strands 3 and 4, may establish stabilizing interactions with the upstream DNA, as proposed for *E. coli* NusG-NTD ([@bib58]).

![The role of NT DNA hairpin.\
(**A**) Model of RfaH-NTD bound to the *ops*-paused TEC. Surface-accessible NT DNA bases are shown as sticks. (**B**) The double C3G + G8C substitution partially restores RfaH-dependent recruitment. The assay was done as in [Figure 2](#fig2){ref-type="fig"}. The position of an RfaH-induced delay in RNAP escape is shown with a blue bar, solid if delay is enhanced.](elife-36349-fig5){#fig5}

To test if DNA secondary structure, rather than the identity of the paired nucleotides, is essential for RfaH recruitment to the TEC, we combined strongly defective C3G and G8C substitutions in a flipped G3:C8 base pair. We found that the double substitution partially restored RfaH recruitment, as reflected by RfaH-induced delay at positions 12/13 ([Figure 5B](#fig5){ref-type="fig"}). We conclude that the C3:G8 base pair (i) can form in the *ops*-paused TEC and (ii) plays an indirect, architectural role in RfaH binding by stabilizing a small DNA loop in which the bases are perfectly positioned to make direct contacts to RfaH-NTD.

Discussion {#s3}
==========

The consensus pause as a versatile regulator {#s3-1}
--------------------------------------------

Our findings portray the consensus pause as a chimeric, versatile target for diverse regulatory proteins. Pausing of RNAP is induced by the conserved flanking sequences and would favor recruitment of regulatory factors kinetically, *via* widening the time window for engagement of proteins in low abundance. The central region of the consensus pause is highly variable, and the primary and secondary structures of the surface-accessible NT DNA strand could mediate direct and indirect readout by a protein ligand. We hypothesize that, in addition to RfaH homologs which could be expected to use a similar mode of binding, other unrelated proteins may employ the same general principle during their recruitment to the elongating RNAP. Moreover, contacts with the NT DNA strand that persist after recruitment may underpin regulation of RNA chain elongation in all cells.

The role of *ops* in RfaH recruitment {#s3-2}
-------------------------------------

Our results confirm that the *ops* element plays several roles in RfaH recruitment. *First*, consistent with the observation of direct contacts with the NT DNA by crosslinking ([@bib3]), RfaH interacts with *ops* residues 4 through 7. The interactions are corroborated by previous 'blind', that is, uninformed by the structure, functional studies of RfaH-NTD in which substitutions of RfaH residues that interact with *ops* were found to cause defects in RfaH function ([@bib7]). However, the pattern of *ops*:RfaH-NTD contacts, and in particular the extrusion of the hairpin, have not been anticipated. We propose that when RNAP pauses at the *ops* site, the NT DNA strand forms a transient hairpin exposed on the surface ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). Autoinhibited RfaH interacts with the loop nucleotides (G4 through A7), stabilizing the hairpin and forming a transient encounter complex ([Figure 1](#fig1){ref-type="fig"}). We observe that T6 flips into a pocket on RfaH-NTD, apparently a common pattern in NT DNA strand contacts since the RNAP σ and β subunits employ analogous capture mechanisms ([@bib5]; [@bib67]).

*Second*, pausing at *ops* appears to be required for efficient RfaH recruitment. Substitutions of *ops* residues that reduce pausing compromise RfaH function, even though they do not make direct contacts to RfaH. While the simplest explanation is that pausing simply prolongs the lifespan of the RfaH target, additional roles of pausing could be considered. RNAP backtracks when paused at *ops* in vitro ([@bib2]), effectively shifting the exposed NT DNA two nucleotides back. RfaH is recruited to RNAP halted two nts upstream from *ops* ([Figure 3](#fig3){ref-type="fig"}), suggesting that backtracking at *ops*, assuming it occurs in vivo, may be needed to place the *ops* bases in an optimal position for direct interactions. However, RfaH binds to a scaffold *ops* TEC locked in the post-translocated state ([@bib42]), arguing that the NT DNA strand may be sufficiently flexible ([@bib25]) to interact with RfaH at several template positions. Although it is also possible that conformational changes that accompany the formation of the paused state may favor RfaH binding to RNAP, recent structures of paused TECs ([@bib20]; [@bib24]) and our observations that RfaH binds to scaffolds in which the RNA strand is present or missing similarly ([@bib3]) do not support this interpretation.

*Third*, given that recruitment of the isolated RfaH-NTD does not require *ops*, we considered a possibility that RfaH contacts to *ops* trigger NTD dissociation from CTD. However, this idea is refuted by our observations that domain interface remains intact in the binary complex, implying that additional interactions with RNAP or nucleic acids relieve autoinhibition. Structural studies of an encounter complex formed when the closed RfaH recognizes *ops* would be required to address this question.

Finally, pausing at *ops* may assist in the recruitment of a ribosome, which is thought to be critical for RfaH-mediated activation of its target genes which lack canonical Shine-Dalgarno elements ([@bib10]). RfaH and NusG make similar contacts to S10 ([@bib11]; [@bib10]) and could bridge RNAP and 30S during translation initiation and 70S during elongation; the *ops*-induced delay could favor the initial RfaH:30S interactions. While a cryo-EM structure of a coupled RNAP:70S complex argues against bridging by NusG or RfaH ([@bib28]), a recent study supports the role of the experimentally determined NusG:S10 interface ([@bib11]) in binding to 70S and transcription-translation coupling in vivo ([@bib48]).

Specific recognition of *ops* by RfaH {#s3-3}
-------------------------------------

Despite low sequence identity (21% as compared to *E. coli* NusG-NTD), *E. coli* RfaH-NTD has the typical fold of all NusG proteins ([Figure 6A,B](#fig6){ref-type="fig"}) and is thought to make similar contacts to the β'CH. However, in contrast to sequence-independent NusG, RfaH requires contacts with the *ops* DNA for recruitment. These interactions are highly specific, as illustrated by strong effects of single base substitutions ([Figure 2](#fig2){ref-type="fig"}) and lack of off-target recruitment in the cell ([@bib6]). Our present data reveal that the specificity of RfaH:DNA contacts is determined by just a few direct interactions, mediated by a secondary structure in the DNA. We observe that the *ops* DNA forms a hairpin which exposes the invariant G5 and T6, the only two nucleobases that establish a base-specific hydrogen-bond network with RfaH-NTD ([Figure 4C](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}), for specific recognition. In RfaH, the basic patch identified by previous analysis ([@bib7]) constitutes the DNA binding site, with only the side chains of K10, H20, R23, and R73 making direct contacts to *ops* ([Figures 4B](#fig4){ref-type="fig"} and [6C](#fig6){ref-type="fig"}). Alanine substitutions of K10, H20, and R73 dramatically compromised the delay of RNAP escape from the *ops* pause, and thus RfaH recruitment ([Figures 4C](#fig4){ref-type="fig"} and [6C](#fig6){ref-type="fig"}, \[[@bib7]\]), in agreement with their base-specific interactions in the RfaH:*ops*9 structure. The R16A substitution also had a strong defect ([@bib7]). However, while one nitrogen atom of the guanidinium group of R16 is in hydrogen bonding distance to the oxygen atom of the G4 base (3.57 Å) in one of the complexes in the asymmetric unit, the distance is larger in the other copy (3.82 Å). Together with the effect of the R16A substitution, this suggests that the R16:G4 interaction may become relevant in the context of the *ops* TEC, where RfaH is more constrained by RfaH:RNAP interactions. Although R23A substitution compromised RfaH recruitment only slightly, our structure reveals that R23 directly contacts T5 *via* its guanidinium group. Q13A, H65A, T66A, and T68A variants showed only mild effects, which may be indirect. Q13 could be necessary to position R16, while H65, T66, and T68 may be involved in interactions with the β subunit gate loop ([@bib51]). High conservation of K10, H20, R23, and R73 residues ([@bib53]) and *ops* sequences ([@bib6]) suggests a common recognition mechanism for all RfaH proteins.

![Specificity of RfaH for *ops*.\
Superposition based on backbone atoms of NusG-NTD (PDB ID 2K06, light blue) and RfaH-NTD (taken from the RfaH:*ops*9 structure, green; root mean square deviation: 4.3 Å). Both proteins in ribbon representation. (**B**) Structure-based sequence alignment of NusG and RfaH. RfaH residues whose substitutions for Ala compromise RfaH recruitment ([@bib7]) are highlighted in red (strongly defective) and orange (moderately defective). RfaH residues that make base-specific interactions with *ops* via their side chains are marked by an asterisk. (**C**) Structure of RfaH-NTD in (left) surface representation colored according to its electrostatic potential (from −3k~B~T/e, red, to +3 ~k~BT/e, blue) and (right) ribbon representation with residues highlighted in (**B**) shown as sticks (C atoms, red or orange; N atoms, blue; O atoms, light red). (**D**) Structure of NusG-NTD (PDB ID 2K06) in (left) surface representation colored according to its electrostatic potential and (right) ribbon representation. Residues corresponding to the amino acids of RfaH highlighted in (**B**) are shown as sticks (C atoms, pink; N atoms, blue; O atoms, light red).](elife-36349-fig6){#fig6}

In contrast, the residues that form the basic patch in RfaH are mostly hydrophobic in *E. coli* NusG ([Figure 6](#fig6){ref-type="fig"}) and are not conserved within the NusG family ([@bib53]), consistent with NusG function as a general transcription factor. However, specific contacts with DNA could explain unusual, pause-enhancing NusG effects on RNA synthesis in some bacteria ([@bib14]; [@bib50]; [@bib63]).

Different read-out modes of the NT DNA strand {#s3-4}
---------------------------------------------

The flipping out of T6 in the *ops* element and its insertion into a pocket on RfaH-NTD is reminiscent of a mechanism utilized by σ to recognize the −10 promoter element during initiation ([@bib5]; [@bib67]). The melted DNA strand is draped across a positively charged surface of σ, with highly conserved −11A and −7T flipped out into deep pockets of σ, whereas nucleotides at positions −10, --9, and −8 are mainly bound *via* extensive interactions between their sugar-phosphate backbone and σ. In the *ops*9:RfaH complex only one base, T6, is flipped out, but the neighboring G5 packs against the RfaH-NTD surface and also establishes base-specific interactions.

Although both RfaH and σ employ base flipping to specifically bind their target sequences, their recognition mechanisms differ in key details. While the RfaH:*ops* interaction relies only on a very limited number of interactions, σ establishes extensive, base-specific contacts. RfaH exhibits only few interactions with the phosphate backbone and recognizes just two bases specifically, whereas σ makes extensive interactions with the phosphate backbone of the NT DNA strand and establishes base-specific contacts not only with −11A and −7T of the −10 region, but also with −6G of the discriminator element ([@bib18]; [@bib67]). Furthermore, in contrast to RfaH, σ uses a wedge residue (W433 in *E. coli *σ^70^), which rotates into the DNA duplex, mimicking the flipped-out base ([@bib5]), a principle that is commonly used by a variety of proteins to stabilize the extrahelical conformation of a flipped-out base ([@bib15]; [@bib31]; [@bib64]; [@bib65]). In contrast, RfaH requires that the NT DNA folds into a hairpin to position the two central *ops* nucleotides for specific recognition. The *ops* hairpin thus constitutes an alternative way of stabilizing a DNA conformation with a flipped-out base.

These differences likely reflect distinct roles of NT DNA:protein interactions in the function of RfaH and σ. Although many examples of σ-dependent pauses that are stabilized by σ contacts to promoter-like elements during elongation have been documented ([@bib43]), the primary role of σ is to mediate promoter recognition and DNA melting ([@bib19]). Interactions with the NT DNA strand are established after initial recruitment to the duplex DNA and are only possible as a result of σ-dependent DNA strand separation. NT DNA:σ interactions are highly specific and utilize the same determinants in promoter and paused complexes ([@bib32]; [@bib66]; [@bib68]). In contrast, RfaH is recruited to the *ops* element in a pre-made transcription bubble and relies on different DNA contacts for initial binding and for sequence-independent post-recruitment activity. Thus, *ops* recognition by RfaH seems to be more similar to sequence readout by σ during σ-induced promoter-proximal pausing than during promoter melting. Overall, base flipping provides an effective means to read sequence as it allows contacts with all atoms of a base and may be a general mechanism to recruit specific transcription factors throughout transcription.

The NT DNA strand as a general target for transcription regulation {#s3-5}
------------------------------------------------------------------

A growing body of evidence supports a key role of the NT DNA in the regulation of transcription. NT DNA contacts to the β and σ subunits ([@bib5]; [@bib67]) determine the structure and stability of promoter complexes, control start site selection, and mediate the efficiency of promoter escape, in part by modulating DNA scrunching ([@bib21]; [@bib40]; [@bib55]; [@bib62]). Upon promoter escape and σ release, the NT DNA loses contacts with RNAP ([@bib25]), except for transient interactions with β that control elongation and pausing ([@bib40]; [@bib45]; [@bib60]). Our results suggest that the NT DNA is sufficiently flexible to adopt stable secondary structures and reveal interesting parallels and differences between DNA recognition by σ and RfaH, which bind to similar sites on transcription complexes *via* high-affinity interactions with the β'CH ([@bib52]) and interact specifically with the NT DNA strand *via* base flipping.

NusG homologs from bacteria and yeast that bind NT DNA specifically may employ similar readout modes, allowing them to exert functions opposing those of *E. coli* NusG ([@bib13]; [@bib63]). The available evidence thus suggests that conformational flexibility of the NT DNA and neighboring RNAP elements may produce rich regulatory diversity despite the short length of the exposed NT DNA strand, mediating recruitment of factors that control initiation, elongation, and termination of transcription in all domains of life.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\                 Designation                                                                   Source or reference                                      Identifiers                                                                  Additional information
  or resource                                                                                                                                                                                                                                                 
  --------------------------------------- ----------------------------------------------------------------------------- -------------------------------------------------------- ---------------------------------------------------------------------------- ------------------------
  Strain, strain background (*E. coli*)   BL21 (λ DE3)                                                                  Novagen                                                  N/A                                                                          

  Strain, strain background (*E. coli*)   DH5α *ΔrfaH* (λ DE3)                                                          [@bib7]                                                  IA lab stock\                                                                
                                                                                                                                                                                 \#149                                                                        

  Recombinant DNA reagent                 list of recombinant plasmids used                                             Table 2                                                                                                                               

  Sequence-based reagent                  *ops*9\                                                                       IDT                                                      N/A                                                                          
                                          GCGGTAGTC                                                                                                                                                                                                           

  Sequence-based reagent                  *ops*12\                                                                      Biomers.net                                              N/A                                                                          
                                          GGCGGTAGCGTG                                                                                                                                                                                                        

  Sequence-based reagent                  T7A1 promoter\                                                                Sigma Aldrich                                            IA lab stock \#2536                                                          
                                          AAAAAGAGTATTGACTTAAAGTCTAACCTATAGGATACTTACAGCCATCGAGCAGGCAGCGGCAAAGCCATGG                                                                                                                                           

  Sequence-based reagent                  DN PCR primer\                                                                Sigma Aldrich                                            IA lab stock \#2536                                                          
                                          AAATAAGCGGCTCTCAGTTT                                                                                                                                                                                                

  Sequence-based reagent                  UP PCR primer\                                                                Sigma Aldrich                                            IA lab stock \#2499                                                          
                                          AAAAAGAGTATTGACTTAAAG                                                                                                                                                                                               

  Sequence-based reagent                  R40 RNA oligo\                                                                IDT DNA Technologies                                     N/A                                                                          
                                          UUUAUCGGCGGUAG                                                                                                                                                                                                      

  Sequence-based reagent                  NT44 DNA oligo\                                                               IDT DNA Technologies                                     N/A                                                                          
                                          CACCACCACGCGGGCGGTAGCGTGCTTTTTTCGATCTTCCAGTG                                                                                                                                                                        

  Sequence-based reagent                  T44 DNA oligo\                                                                IDT DNA Technologies                                     N/A                                                                          
                                          CACTGGAAGATCGAAAAAAGCACGCTACCGCCCGCGTGGTGGTG                                                                                                                                                                        

  Peptide, recombinant protein            *E. coli* RfaH (transcription assays, NMR)                                    [@bib8]                                                  N/A                                                                          

  Peptide, recombinant protein            *E. coli* RfaH (crystallization)                                              [@bib59]                                                 N/A                                                                          

  Peptide, recombinant protein            *E. coli* RNA polymerase                                                      [@bib56]                                                 N/A                                                                          

  Peptide, recombinant protein            Exo III nuclease                                                              New England Biolabs                                      Cat\#: MO206                                                                 

  Peptide, recombinant protein            T4 polynucleotide kinase                                                      New England Biolabs                                      Cat\#: MO0201                                                                

  Commercial assay or kit                 QIAquick PCR purification kit                                                 Qiagen                                                   Cat\#: 28104                                                                 

  Commercial assay or kit                 QIAquick Nucleotide Removal Kit                                               Qiagen                                                   Cat\#: 28306                                                                 

  Chemical compound, drug                 (^15^NH)~4~SO~4~                                                              Campro Scientific                                        Cat\#: CS01-185_148                                                          

  Chemical compound, drug                 D2O                                                                           Eurisotop                                                Cat\#: D216L                                                                 

  Chemical compound, drug                 ApU                                                                           Sigma-Aldrich                                            Cat \#: A6800                                                                

  Chemical compound, drug                 \[α−32P\]-CTP                                                                 Perkin Elmer                                             Cat\#: BLU008H                                                               

  Chemical compound, drug                 Rifapentin                                                                    [@bib4]                                                  N/A                                                                          

  Chemical compound, drug                 PEG monomethyl ether 500                                                      Sigma-Aldrich                                            Cat\#: 202487                                                                

  Chemical compound, drug                 4-(2-hydroxyethyl)piperazineethanesulfonic acid (HEPES) for crystallization   Sigma-Aldrich                                            Cat\#: H4034                                                                 

  Chemical compound, drug                 MgCl2 for crystallization                                                     Merck                                                    Cat\#: 105833                                                                

  Chemical compound, drug                 Glutaraldehyde for crystallization                                            Fluka                                                    Cat\#: 49629                                                                 

  Chemical compound, drug                 Tris(hydroxymethyl)aminomethane (Tris) for crystallization                    Roth                                                     Cat\#: 4855.3                                                                

  Chemical compound, drug                 KCl for crystallization                                                       VWR                                                      Cat\#: 26764.298                                                             

  Chemical compound, drug                 Dithiothreitol (DTT) for crystallization                                      Roth                                                     Cat\#: 6908.1                                                                

  Chemical compound, drug                 Perfluoropolyether cryo oil                                                   Hampton Research                                         Cat\#: HR2-814                                                               

  Software, algorithm                     PyMol v. 1.7                                                                  The PyMOL Molecular Graphics System, Schrödinger, LLC.   <https://pymol.org/2/>                                                       

  Software, algorithm                     COOT                                                                          [@bib17]                                                 <https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/>                      

  Software, algorithm                     XDS                                                                           [@bib23]                                                 <http://xds.mpimf-heidelberg.mpg.de/>                                        

  Software, algorithm                     XDSAPP                                                                        [@bib54]                                                 <https://www.helmholtz-berlin.de/forschung/oe/np/gmx/xdsapp/index_en.html>   

  Software, algorithm                     PHASER                                                                        [@bib34]                                                                                                                              

  Software, algorithm                     PHENIX suite                                                                  [@bib1]                                                  <https://www.phenix-online.org/>                                             

  Software, algorithm                     LigPlot                                                                       [@bib61]                                                 <https://www.ebi.ac.uk/thornton-srv/software/LIGPLOT/>                       

  Software, algorithm                     NMRViewJ                                                                      One Moon Scientific, Inc.                                <http://www.onemoonscientific.com/nmrviewj>                                  

  Software, algorithm                     GraFit v. 6.0.12                                                              Erithacus Software Ltd.                                  <http://www.erithacus.com/grafit/>                                           

  Software, algorithm                     MatLab v. 7.1.0.183                                                           The MathWorks, Inc.                                      <https://de.mathworks.com/products/matlab.html>                              

  Software, algorithm                     ImageQuant                                                                    GE Healthcare Life Sciences                              [www.gelifesciences.com/](http://www.gelifesciences.com/)                    

  Software, algorithm                     PISA Server                                                                   [@bib29]                                                 <http://www.ebi.ac.uk/pdbe/pisa/>                                            

  Other                                   24-well VDXm plates with sealant                                              Hampton Research                                         HR3-306                                                                      
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plasmids {#s4-1}
--------

Plasmids are listed in [Table 2](#table2){ref-type="table"}.

10.7554/eLife.36349.015

###### Plasmids

  Name                      Description                                                 Source
  ------------------------- ----------------------------------------------------------- -----------
  *ops* variants                                                                        
  pIA1087                   P~BAD~‒*ops*^WT^‒*luxCDABE*                                 [@bib10]
  pZL6                      P~BAD~‒*ops*(G2C)‒*luxCDABE*                                This work
  pZL7                      P~BAD~‒*ops*(A7T)‒*luxCDABE*                                This work
  pZL12                     P~BAD~‒*ops*(T11G ‒*luxCDABE*                               This work
  pZL14                     P~BAD~‒*ops*(G5A)‒*luxCDABE*                                This work
  pZL21                     P~BAD~‒*ops*(G4C)‒*luxCDABE*                                This work
  pZL22                     P~BAD~‒*ops*(T6A)‒*luxCDABE*                                This work
  pZL23                     P~BAD~‒*ops*(G8C)‒*luxCDABE*                                This work
  pZL24                     P~BAD~‒*ops*(G12C)‒*luxCDABE*                               This work
  pZL25                     P~BAD~‒*ops*(G1C)‒*luxCDABE*                                This work
  pZL26                     P~BAD~‒*ops*(C3G)‒*luxCDABE*                                This work
  pZL27                     P~BAD~‒*ops*(C9G)‒*luxCDABE*                                This work
  pZL28                     P~BAD~‒*ops*(G10C)‒*luxCDABE*                               This work
  pIA1286                   P~BAD~‒*ops*(C3G + G8C)‒*luxCDABE*                          This work
  Gene expression vectors                                                               
  pVS10                     P~T7~ promoter-- *E. coli rpoA--rpoB--rpoC*^His6^--*rpoZ*   [@bib8]
  pVS12                     *E. coli rfaH* in pTYB1                                     [@bib59]
  pIA238                    *E. coli rfaH* in pET28a                                    [@bib3]

Gene expression and protein purification {#s4-2}
----------------------------------------

RfaH used in crystallization experiments and in vitro transcription assays was produced as described ([@bib59]), as was RfaH used in NMR experiments ([@bib10]), and RNAP for in vitro transcription assays ([@bib56]). All expression plasmids are listed in [Table 2](#table2){ref-type="table"}.

The purity was checked by SDS-PAGE, the absence of nucleic acids was checked by recording UV/Vis spectra on a Nanodrop ND-1000 spectrometer (PEQLAB, Erlangen, Germany). Concentrations were determined by measuring the absorbance at 280 nm (*A*~280~) in a 10 mm quartz cuvette (Hellma, Müllheim, Germany) on a Biospectrometer basic (Eppendorf, Hamburg, Germany).

Isotopic labeling {#s4-3}
-----------------

^15^N-labeled proteins were obtained from *E. coli* cells grown in M9 minimal medium containing (^15^NH~4~)~2~SO~4~ (Campro Scientific, Berlin, Germany) as sole nitrogen source ([@bib35]; [@bib47]). Expression and purification were as described for the production of unlabeled proteins.

Crystallization {#s4-4}
---------------

RfaH was cocrystallized with *ops*9 DNA (5'-GCG GTA GTC-3'; IDT, Coralville IA) based on a published condition ([@bib59]). The protein was dialyzed against crystallization buffer (10 mM tris(hydroxymethyl)aminomethane (Tris)/HCl (pH 7.8), 50 mM KCl, 2 mM DTT). *ops*9 (20 mM in H~2~O) was diluted with crystallization buffer and a 5-fold molar excess of MgCl~2~ before being added to RfaH in a molar ratio of 1:1 (complex concentration 400 μM).

The RfaH:*ops*9 complex was crystallized by vapor diffusion techniques at 4°C using the hanging-drop setup from a reservoir containing 21% (v/v) PEG monomethyl ether (MME) 550, 44.4 mM 4-(2-hydroxyethyl)−1-piperazineethanesulfonic acid (HEPES) (pH 7.0), 4 mM MgCl~2~ (2 µl protein:DNA solution +2 µl reservoir). Due to crystal instability crosslinking was carried out prior to harvesting by placing 4 µl of 25% (v/v) glutaraldehyde next to the crystallization drop and resealing the well. After an incubation for 2 hr at 4°C the crystal was immersed in perfluoropolyether (Hampton Research) before being frozen in liquid nitrogen.

Data collection and refinement {#s4-5}
------------------------------

Diffraction data were collected at the synchrotron beamline MX-14.1 at Helmholtz-Zentrum Berlin (HZB) at the BESSY II electron storage ring (Berlin-Adlershof, Germany) ([@bib38]) at 100 K using a Pilatus 6M detector and a wavelength of 0.9184 Å. Data were processed and scaled with XDS ([@bib22]; [@bib23]) within the graphical user interface of XDSAPP ([@bib54]). To obtain initial phases Patterson search techniques with homologous search model were performed by PHASER ([@bib34]) using free RfaH (PDB ID 2OUG) as search model. To minimize the model bias a simulated annealing energy minimization using the PHENIX program suite ([@bib1]) was performed. Subsequent rounds of model building and refinement were performed using COOT ([@bib17]) and the PHENIX program suite ([@bib1]).

NMR spectroscopy {#s4-6}
----------------

NMR experiments were performed on Bruker *Avance* 700 MHz spectrometer, which was equipped with a cryo-cooled, inverse triple resonance probe. Processing of NMR data was carried out using in-house routines. 2D spectra were visualized and analyzed by NMRViewJ (One Moon Scientific, Inc., Westfield, NJ, USA), 1D spectra by MatLab (The MathWorks, Inc., Version 7.1.0.183). Measurements involving RfaH were conducted at 15°C, measurements with isolated *ops*9 at temperatures from 4-30°C as indicated. The initial sample volume was 500 μl, if not stated otherwise. The resonance assignments for the backbone amide protons of RfaH was from a previous study ([@bib10]).

The components in the measurement of the ^15^N-RfaH:*ops*12 (5'-GGC GGT AGC GTG-3'; biomers.net GmbH, Ulm, Germany) interaction were in 10 mM K~2~HPO~4~/KH~2~PO~4~ (pH 7.5), 50 mM KCl, 10% D~2~O. For the determination of the secondary structure of *ops*9 (5'-GCG GTA GTC-3'; metabion international AG, Planegg/Steinkirchen, Germany) the DNA was in 20 mM Na~2~HPO~4~/NaH~2~PO~4~ (pH 7.0), 50 mM NaCl, 1 mM MgCl~2~, 10% D~2~O.

Interaction studies with chemical shifts changes in the fast regime on the chemical shift timescale were analyzed by calculating the normalized chemical shift perturbation (Δδ~norm~) according to [Equation 1](#equ1){ref-type="disp-formula"} for \[^1^H,^15^N\] correlation spectra.$$\Delta\delta_{\text{norm}} = \ \sqrt{\left( {\Delta\delta^{1}H} \right)^{2} + \left\lbrack {0.1 \cdot \left( {\Delta\delta^{15}N} \right)} \right\rbrack^{2}}$$where Δδ is the resonance frequency difference in ppm.

RfaH:*ops* TEC model {#s4-7}
--------------------

The composite model of RfaH bound to the *ops*-paused TEC was generated based on an available cryo EM structure of the *E. coli* TEC ([@bib25]) and the complex of *P. furiosus* Spt5 bound to the RNAP clamp domain ([@bib33]). The Spt5:clamp complex was superimposed on the β' subunit of the *E. coli* TEC, and then the RfaH:*ops*9 structure was positioned by superimposing RfaH-NTD on the NTD of Spt5 using COOT ([@bib17]). Nucleotides 2, 9, and 10 of *ops*9 were manually moved in COOT ([@bib17]) to superimpose with the NT strand keeping the C3:G8 base pair intact so that G2 is the first paired nucleotide on the upstream end of the bubble. The sequence of the remaining *ops* element as well as the corresponding sequences in the T DNA strand and the RNA were adapted.

Luciferase reporter assays {#s4-8}
--------------------------

Luciferase reporter assays were performed as described in ([@bib7]). A selected *lux* reporter plasmid ([Table 2](#table2){ref-type="table"}) was co-transformed with a plasmid containing the *rfaH* gene (pIA947) or an empty vector (pIA957) into IA149 (*ΔrfaH* in DH5αDE3) and plated on 100 μg/ml carbenicillin (Carb), 50 μg/ml chloramphenicol (Cam) lysogeny broth (LB) plates. Single colonies were inoculated into 3 ml of LB supplemented with Carb and Cam and incubated at 37°C. Overnight cultures were diluted into fresh LB with the antibiotics to optical density at 600 nm (*OD*~600~) ∼0.05 and grown at 37°C for 6 hrs. No induction was required for the P~BAD~-controlled *lux* or P~trc~-controlled *rfaH*, as leaky expression from both these vectors was enough to produce a reproducible signal. Luminescence was measured at approximately equal density for all cultures in triplicates using FLUOstar OPTIMA plate reader (BMG LABTECH, Offenburg, Germany) and normalized for cell density. Three sets of assays were done for each condition, with 3 biological replicates and 6 technical replicates each. We note that low levels of luciferase expression in the absence of RfaH are associated with large errors.

In vitro transcription assays {#s4-9}
-----------------------------

Templates for in vitro transcription were made by PCR amplifying pIA1087 (WT *ops*) or the plasmids having *ops* substitutions ([Table 2](#table2){ref-type="table"}) with a T7A1 promoter-encoding primer (5'-AAAAAGAGTATTGACTTAAAGTCTAACCTATAGGATACTTACAGCCATCGAGCAGGCAGCGGCAAAGCCATGG-3') and a complementary downstream primer (DN: 5'-AAATAAGCGGCTCTCAGTTT-3'). A second PCR was performed with primers 5'-AAAAAGAGTATTGACTTAAAG-3' and DN to reduce the concentration of the unused large primer, followed by purification *via* a QIAquick PCR purification kit (Qiagen, Valencia, CA). The resulting linear templates contained T7A1 promoter followed by an initial 24 nt T-less transcribed region; the run-off transcript generated on these templates is 79-nt long. Linear DNA template (30 nM), holo RNAP (40 nM), ApU (100 µM), and starting NTP subsets (1 µM CTP, 5 µM ATP and UTP, 10 µCi \[α^32^P\]-CTP, 3000 Ci/mmol) were mixed in 100 µl of TGA2 (20 mM Tris-acetate, 20 mM Na-acetate, 2 mM Mg-acetate, 5% glycerol, 1 mM DTT, 0.1 mM EDTA, pH 7.9). Reactions were incubated for 15 min at 37°C; thus halted TECs were stored on ice. RfaH (or an equal volume of storage buffer) was added to the TEC, followed by a 2 min incubation at 37°C. Transcription was restarted by addition of nucleotides (10 µM GTP, 150 µM ATP, CTP, and UTP) and rifapentin to 25 µg/ml. Samples were removed at time points indicated in the figures and quenched by addition of an equal volume of STOP buffer (10 M urea, 60 mM EDTA, 45 mM Tris-borate; pH 8.3). Samples were heated for 2 min at 95°C and separated by electrophoresis in denaturing 8% acrylamide (19:1) gels (7 M Urea, 0.5X TBE). The gels were dried and RNA products were visualized and quantified using FLA9000 Phosphorimaging System, ImageQuant Software, and Microsoft Excel. In vitro transcription assays were carried out in triplicates and averaged.

Exonuclease footprinting {#s4-10}
------------------------

To assemble a scaffold TEC, the RNA primer and the T DNA strand were end-labeled with \[γ^32^P\]-ATP using PNK (NEB). Following labeling, oligonucleotides were purified using QIAquick Nucleotide Removal Kit (Qiagen). To assemble a scaffold, RNA and T DNA oligonucleotides were combined in PNK buffer and annealed in a PCR machine as follows: 5 min at 45°C; 2 min each at 42, 39, 36, 33, 30, and 27°C, 10 min at 25°C. 12 pmoles of T/RNA hybrid were mixed with 14 pmoles of His-tagged core RNAP in 30 μl of TB \[20 mM Tris-Cl, 5% glycerol, 40 mM KCl, 5 mM MgCl~2~, 10 mM β-mercaptoethanol, pH 7.9\], and incubated at 37°C for 10 min. 15 μl of His-Select HF Nickel Affinity Gel (Sigma Aldrich) was washed once in TB and incubated with 20 μg Bovine Serum Albumin in a 40 μl volume for 15 min at 37°C, followed by a single wash step in TB. The T/RNA/RNAP complex was mixed with the Affinity Gel for 15 min at 37°C on a thermomixer (Eppendorf) at 900 rpm, and washed twice with TB. 30 pmoles of the NT oligonucleotide were added, followed by incubation for 20 min at 37°C, one 5 min incubation with TB-1000 in a thermomixer, and five washes with TB. The assembled TECs were eluted from beads with 90 mM imidazole in a 15 μl volume, purified through a Durapore (PVDF) 0.45 μm Centrifugal Filter Unit (Merck Millipore), and resuspended in TB. The TEC was divided in two aliquots; one was incubated with 100 nM RfaH and the other with storage buffer for 3 min at 37°C. For each time point, 5 μl TEC were mixed with 5 μl of Exo III (NEB, 40 U) and incubated at 21°C. At times indicated in the [Figure 3](#fig3){ref-type="fig"} legend, the reactions were quenched with an equal volume of Stop buffer (8 M Urea, 20 mM EDTA, 1x TBE, 0.5% Brilliant Blue R, 0.5% Xylene Cyanol FF).

Programs {#s4-11}
--------

All molecular structures were visualized using The PyMOL Molecular Graphics System (Version 1.7, Schrödinger, LLC.) Superpositions of protein and nucleic acid structures were prepared with COOT ([@bib17]). Interactions between *ops*9 and RfaH were analyzed using LigPlot ([@bib61]). The size of the RfaH:*ops*9 interface was calculated by the PDBePISA server ([@bib29]).

Data availability {#s4-12}
-----------------

Coordinates and structure factor amplitudes of the RfaH:*ops*9 complex are deposited in the Protein Data Bank under ID code 5OND.
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Data availability {#s7}
-----------------

Diffraction data have been deposited in PDB under the accession code 5OND. All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2 and 4. The PDB file of the RfaH:ops TEC model has been provided.

The following dataset was generated:

Zuber PKArtsimovitch IRoesch PKnauer SH2018RfaH from Escherichia coli in complex with ops DNA<http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OND>Publicly available at the RCSB Protein Data Bank (accession no. 5OND)
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Thank you for submitting your article \"The universally-conserved transcription factor RfaH is recruited to a hairpin structure of the non-template DNA strand\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Gisela Storz as the Senior Editor. One of the three reviewers, Richard Ebridght, has agreed to reveal his identity.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Zuber et al., combined structural and biochemical studies to shed light on the mechanism of the transcription antitermination factor RfaH, a representative of the NusG/Spt5 family of universally conserved factors, which expands the impact of this research. The authors present evidence that RfaH is recruited to a transcription elongation complex (TEC) at an operon polarity suppression (ops) site through a combination of sequence-dependent TEC pausing at ops, and sequence-dependent DNA-hairpin formation and base flipping in the transcription-bubble non-template strand of the TEC paused at ops. They demonstrate that the nt strand of the RfaH-binding site, ops, adopts a hairpin conformation with a flipped-out base, allowing for structure- and sequence-specific read-out of transcription signals. This discovery has implications not just for RfaH mechanism of action, but for our understanding of transcription regulation by signals embedded in DNA as well as mechanisms of recruitment of non-specific regulatory factors, such as DNA helicase UvrD. Conclusions are well supported by the reported NMR, and X-ray crystallographic data, as well as in vivo, and in vitro assays and are also consistent with previous mapping and computational discovery of ntDNA-binding site in RfaH NTD (Belogurov et al., 2010; Svetlov and Nudler, 2012). In conclusion, the manuscript provides important structural and functional insights into the mechanism of transcription regulation by RfaH and related factors, suggesting that sequence-dependent pausing and DNA-hairpin formation can function together to mediate sequence-specific recognition of DNA signals during transcription elongation. The findings should be of broad interest to researchers in transcription and transcriptional regulation. It is thus appropriate for publication once the following suggestions are attended.

Essential revisions:

\- The functional importance of the observed interactions for binding affinity and binding specificity (subsection "Structural analysis of RfaH:*ops* contacts") should be demonstrated experimentally with minimal effort. Although biochemical results are presented to support the inferred DNA secondary structure, no biochemical results are presented to support the inferred protein-DNA interactions. This is an important omission in view of the unusually, potentially worrisomely, small size of the inferred protein-DNA interface: \"only 214 A\^2.\") Just 4 amino acids (K10, H20, R23, and R73) and 2 bases (T6 and G5) are inferred to be important for specificity. Accordingly, a comprehensive analysis -involving substitution of each amino acid by Ala, and quantification of affinities of wild-type and Ala-substituted RfaH derivatives for wild-type, T5-substituted, and G-6-substituted ops derivatives- would be possible.

\- The current description of the model for RfaH loading and action is vague (no real Figure legend for Figure 1) and it would be useful to be more concrete both in what is known and what is not known. E.g. in the modelled RfaH-TEC complex, which is very compelling, RfaH is bound to ops in the context of a TEC. The TEC is in a register where U11 would be post-translocated or possibly pre-translocated (assuming G12 has been added). It was believed that the backtracking happens at the U11 pause site (according to Figure 3, Artsimovitch and Landick, 2000) but in that case it is not easy to see how RfaH can bind to ops because the NT DNA should be shifted downstream by at least one, possibly two bases. Do the authors think that RNAP is backtracked at U11? Do the authors think that RfaH binds to this state or do they think it binds to a post-translocated TEC at U11?

\- The ExoIII footprints seem to argue against backtracking since the tDNA gets shorter as RNAP progresses towards U11 and the results are not consistent with the schematics at the bottom of Figure 3. It seems that the major ExoIII cleavage products in absence of RfaH are not labelled correctly: G8 should be 14, C9 should be 13, G10 should be 13/12, U11 should be 12. Likewise, in the presence of RfaH, the ExoIII footprints also get shorter (not to the same extent) -- major ExoIII cleavage products seem to be 19 for C9, 19/18 for G10 and 18 for U11. These results argue against backtracking because ExoIII gains access to the tDNA strand as RNAP adds bases to the RNA 3\'-end. Authors should clarify and discuss this.

10.7554/eLife.36349.022

Author response

Essential revisions:

> \- The functional importance of the observed interactions for binding affinity and binding specificity (subsection "Structural analysis of RfaH:ops contacts") should be demonstrated experimentally with minimal effort. Although biochemical results are presented to support the inferred DNA secondary structure, no biochemical results are presented to support the inferred protein-DNA interactions. This is an important omission in view of the unusually, potentially worrisomely, small size of the inferred protein-DNA interface: \"only 214 A\^2.\") Just 4 amino acids (K10, H20, R23, and R73) and 2 bases (T6 and G5) are inferred to be important for specificity. Accordingly, a comprehensive analysis -involving substitution of each amino acid by Ala, and quantification of affinities of wild-type and Ala-substituted RfaH derivatives for wild-type, T5-substituted, and G-6-substituted ops derivatives- would be possible.

We currently do not have an assay that would allow us to measure RfaH affinities to the EC directly and quantitatively; an EMSA with ^32^P-labeled RfaH that we used in (Artsimovitch and Landick, 2002) is messy and semi-quantitative. We use an indirect way to assess defects in recruitment by measuring RNAP retention 1 and 2 nucleotides downstream from the *ops* site (referred to as 12 and 13 in the current manuscript). We assume that the strength of RfaH contacts to the NT strand is reflected in the delay in RNAP escape from the *ops* site, but this is not a true affinity measurement. Moreover, only a fraction of RNAP is delayed downstream from the *ops* site. Using this assay, we showed that K10A, H20A, and R73A substitutions had strong defects in delaying RNAP escape from *ops*, whereas R23A had a moderate effect (Belogurov et al., 2010). Based on these results, we proposed that K10, H20, R23, and R73 directly interact with the *ops* DNA.

In light of the reviewers' concerns about the small size of the RfaH:*ops*9 interaction surface, we recalculated the interface using the PISA server. We found that the interface comprises 420Å^2^ (average of both complexes in the asymmetric unit), a value updated in the revised manuscript. The crystal structure and the NMR data presented in the current work and a cryoEM structure of RfaH:*ops* EC obtained in the Darst lab support this interpretation and reveal additional contacts that were not predicted by modeling.

We have already demonstrated the importance of RfaH K10, H20, R23, and R73 (Belogurov et al., 2010) and G5 and T6 *ops* residues (this work) in RfaH function in vitro and in vivo and we do not yet have an assay to provide adequate quantitative analysis of RfaH binding to its real target, the EC. Thus, we cannot properly carry out a thorough analysis of these interactions in a reasonable time frame.

We agree that a systematic analysis of RfaH:EC interactions would be necessary to validate structural observations, particularly because the details of RfaH:DNA contacts are not identical. However, this cannot be achieved with "a minimal effort" because roles of all determinants, not just RfaH K10, H20, R23, R73 and G5/T6 in *ops*, need to be probed, and because we need to develop an equilibrium binding assay to probe contributions of RfaH and DNA residues implicated by X-ray and cryoEM structures.

At the same time, a manuscript reporting the cryoEM structure of RfaH-*ops* EC is expected to be accepted any day now. This manuscript was submitted five months after the results of the current study have been communicated to the authors and went through review at Cell with a lightning speed. Given these developments, we cannot afford a significant delay in publication. Notably, the two manuscripts are complementary because the Darst manuscript, on which IA and YN are coauthors, does not present any functional data on the NT DNA determinants and conformation.

To better describe what is known about RfaH:DNA interactions, we revised the text and figures to summarize the available functional data about the RfaH:DNA contacts. We indicated the demonstrated effects of RfaH substitutions on recruitment to *ops* (Belogurov et al., 2010) in Figure 4C and Figure 6 and discussed the observed effects of RfaH substitutions in the light of our RfaH:*ops*9 complex structure.

> \- The current description of the model for RfaH loading and action is vague (no real Figure legend for Figure 1) and it would be useful to be more concrete both in what is known and what is not known. E.g. in the modelled RfaH-TEC complex, which is very compelling, RfaH is bound to ops in the context of a TEC. The TEC is in a register where U11 would be post-translocated or possibly pre-translocated (assuming G12 has been added). It was believed that the backtracking happens at the U11 pause site (according to Figure 3, Artsimovitch and Landick, 2000) but in that case it is not easy to see how RfaH can bind to ops because the NT DNA should be shifted downstream by at least one, possibly two bases. Do the authors think that RNAP is backtracked at U11? Do the authors think that RfaH binds to this state or do they think it binds to a post-translocated TEC at U11?

Backtracking by 1 and 2-3 nt is observed (by Gre-assisted cleavage) in ECs stalled by substrate deprivation G10 and U11 ECs, respectively, in the absence of RfaH; no backtracking is seen in C9 EC. RfaH inhibits backtracking if added to the preformed ECs because it stabilizes the -10 bp at the upstream fork junction, which has to melt for backtracking to occur, as inferred from an increase in inter-strand DNA crosslinking by psoralen. These data are from a manuscript that has been just accepted for publication by Nedialkov et al.

We assume that in vivo RfaH is recruited at U11 because a strong pause at this position was observed by permanganate footprinting (Leeds and Welch, 1996) and later by NET seq, and because mutations that interfere with RNAP pausing at U11 compromise RfaH function, but we do not know whether this complex is pre-, post-, hybrid- (Guo et al., 2018 and Kang et al., 2018), or reverse-translocated. Because RfaH binds to scaffolds in which the RNA strand is present or missing similarly (Artsimovitch and Landick, 2002), it is likely that RfaH primarily senses the NT DNA conformation during the initial recruitment and binds to the EC at different positions and in different translocation states, owing to the inherent flexibility of the NT DNA. RfaH binds to the U11 *ops* EC which is backtracked but also to the *ops* EC in which both RNA and T DNA are post-translocated in the cryoEM structure of RfaH:*ops*EC; in the latter complex, RNA translocation is forced by the scaffold topology, and the NT DNA forms a hairpin with the C3:G8 bp.

We modified the text and the legend of Figure 1 to provide more details on what is and what is not known about the life cycle of RfaH. We also expanded the discussion of RfaH recruitment in the revised manuscript.

> \- The ExoIII footprints seem to argue against backtracking since the tDNA gets shorter as RNAP progresses towards U11 and the results are not consistent with the schematics at the bottom of Figure 3. It seems that the major ExoIII cleavage products in absence of RfaH are not labelled correctly: G8 should be 14, C9 should be 13, G10 should be 13/12, U11 should be 12. Likewise, in the presence of RfaH, the ExoIII footprints also get shorter (not to the same extent) -- major ExoIII cleavage products seem to be 19 for C9, 19/18 for G10 and 18 for U11. These results argue against backtracking because ExoIII gains access to the tDNA strand as RNAP adds bases to the RNA 3\'-end. Authors should clarify and discuss this.

We apologize for a cryptic description of the ExoIII data. We used ExoIII as a reporter of RfaH recruitment: an extension of ExoIII upstream protection is due to RfaH effects on the NT DNA and the upstream DNA duplex trajectories. RfaH induces a strong block at C9, G10, and U11 ECs, consistent with its recruitment at these positions. In Figure 3, ExoIII footprint boundaries are labeled with respect to the RNA 3' end; in a completely post-translocated EC, RNAP protects 14 upstream bp from ExoIII (9 bp RNA:DNA hybrid + 5 extra bp), in a half- translocated (Guo et al., 2018 and Kang et al., 2018) or pre-translocated EC-- 15 bp. G8 EC, in which the upstream RNA is not complementary to the T DNA, is post-translocated (the reviewer is correct and this number should have been 14). C9 is also post-translocated, the T DNA becomes 1 nt shorter, and only 1 predominant species is observed. In G10, even both 14- and 15- products are seen, whereas in U11, an additional backtracked (16) species is seen. Exo III may not be an ideal probe because once ExoIII cleaves the DNA, RNAP cannot go back. We infer the translocation register in these complexes from sensitivity to Gre cleavage (Nedialkov et al., 2018), but the Exo probing also shows that RNAP is reluctant to move forward as it approaches *ops*.

We expanded the section on ExoIII probing and modified Figure 3 and its legend to make it more clear.
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